Sterigenics Invests More Than $10 Million to Expand Operations
Sterigenics International LLC, a global leader in outsourced contract sterilization services, announces that it will invest more than $10 million to expand operations in Atlanta, Dallas and Belgium.
“Strong global customer demand is driving this expansion,” says Philip Macnabb, president and COO of Sterigenics International LLC. “This past year has seen growing demand for our outsourced sterilization services. We are making these strategic expansions as well as our recently completed acquisition of FTSI, a gamma sterilization operation outside of Tampa Florida, to prepare for anticipated growth in these areas.”
The Sterigenics Atlanta facility, located for more than 20 years in suburban Smyrna, Ga., will add a 30-pallet ethylene oxide chamber, increasing processing capacity two million cubic feet per year. Space will be built out for an additional aeration room to accommodate the increased production. The location offers sterilization of medical products, validation capabilities and SteriPro lab services.
The Sterigenics Dallas facility, located in suburban Grand Prairie, Texas, will increase ethylene oxide processing capacity by three million cubic feet per year. A build out will produce expanded pre-conditioning and aeration rooms, with completion by January 2015. Sterigenics has operated at the site since 2003 and offers sterilization of medical products, validation capabilities and SteriPro lab services.
Petit-Rechain, Belgium is one of Sterigenics largest locations, offering Ethylene Oxide sterilization, SteriPro lab services, validation and cycle development capabilities. A 32-pallet chamber will be installed, bringing the total number of chambers to 14. The additional chamber will result in two million cubic feet of additional ethylene oxide processing capacity and will be operational by year end.
Source: Sterigenics International LLC
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
